BioNTech says it will start cancer vaccine trials in the UK from September

The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.

from Health and Science https://ift.tt/cnTJex4
https://ift.tt/KDvA9a2
https://ift.tt/79OzfES